亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

精胺四***

 
 
單價 28000.00 / 千克對比
銷量 暫無
發貨 江蘇蘇州市付款后3天內
庫存 50千克起訂1千克
品牌 麥輪
過期 長期有效
更新 2023-03-07 16:26
 

蘇州麥輪生物科技有限公司

企業會員第5年
資料未認證
保證金未繳納
詳細說明
 產品名稱:精胺四***
中文別名:精胺***;N,N'-雙(3-胺丙基)-1,4-丁二胺四***;四氫氯精胺;***精胺;N,N′-雙(3-氨丙基)-1,4-丁二胺四***;四***精胺
英文名稱:Spermine tetrahydrochloride
英文別名:N,N'-Bis(3-Aminopropyl)-Butane-1,4-Diamine Tetrahydrochloride; N,N'-Bis(3-Aminopropyl)-1,4-Butanediamine4hcl; N,N'-Bis-(3-Aminopropyl)-1,4-Diaminobutane Tetrahydrochloride; N,N'-Bis(3-Aminopropyl)-1,4-Butanediamine Tetrahydrochloride; Neuridine Hydrochloride;Neuridine Tetrahydrochloride;Musculamine Hydrochloride;Musculamine Tetrahydrochloride
CAS:306-67-2
分子式:C10H30Cl4N4
分子量:348.18
純度:98%
外觀與性狀: 類白色粉末
包裝:1kg/包
用途:膳食補充原料
 
舉報收藏 0評論 0
更多>本企業其它產品
酮戊二酸鎂 乳清酸鋰 178261-41-1 Nefiracetam N-(5-羥基煙酰)-L-谷氨酸 9-甲基-Β-咔啉 RU58841 1-(金剛烷-1-羰基)-吡咯烷-2-羧酸
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |